首页> 美国卫生研究院文献>Postpy w Kardiologii Interwencyjnej = Advances in Interventional Cardiology >Ultra-low contrast coronary angiography and zero-contrast percutaneous coronary intervention for prevention of contrast-induced nephropathy: step-by-step approach and review
【2h】

Ultra-low contrast coronary angiography and zero-contrast percutaneous coronary intervention for prevention of contrast-induced nephropathy: step-by-step approach and review

机译:超低对比冠状动脉造影和零对比度经皮冠状动脉介入治疗可预防对比剂诱发的肾病:循序渐进的方法和综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Contrast-induced nephropathy is a serious complication after intravascular administration of iodinated contrast media and is associated with numerous adverse outcomes. Its prevalence is particularly high in patients with multiple comorbidities who undergo coronary angiography and percutaneous coronary intervention (PCI). Currently, the only effective method to prevent contrast-induced kidney injury is adequate hydration and a reduction of contrast volume during the intervention. Recently, new approaches aiming to minimize contrast usage have been proposed, i.e., ultra-low contrast angiography and zero-contrast PCI. However, neither tutorials for these techniques nor reviews of their outcomes exist in the literature, and therefore dissemination of these approaches among the interventional community may be limited. This article presents a step-by-step description on how to perform ultra-low coronary angiography and zero-contrast PCI, which should help invasive cardiologists to adopt these techniques in daily practice. A review of clinical studies, case series and single case reports regarding these methods is also provided. Despite the promising results, such procedures still require some improvements and confirmation of their effectiveness as well as safety in large clinical studies. This article aims to spread these new techniques throughout the interventional community, which is paramount for their further development and wider utilization.
机译:造影剂引起的肾病是在血管内施用碘造影剂后的严重并发症,并伴有许多不良后果。在患有多种合并症的患者中,接受冠状动脉造影和经皮冠状动脉介入治疗(PCI)的患病率尤其高。当前,预防造影剂引起的肾脏损伤的唯一有效方法是在干预过程中充分补充水分并降低造影剂体积。最近,已经提出了旨在最小化造影剂使用的新方法,即,超低造影血管造影和零对比度PCI。但是,文献中既没有这些技术的教程,也没有对它们的结果进行评论,因此在干预社区中这些方法的传播可能受到限制。本文分步介绍了如何执行超低冠状动脉造影和零对比度PCI,这将有助于有创心脏病专家在日常实践中采用这些技术。还提供了有关这些方法的临床研究,病例系列和单个病例报告的综述。尽管取得了令人鼓舞的结果,但此类程序仍需要进行一些改进,并在大型临床研究中确认其有效性以及安全性。本文旨在将这些新技术传播到整个介入社区,这对于它们的进一步发展和更广泛的利用至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号